Skip to main content
. 2021 Feb 16;9(2):e001230. doi: 10.1136/jitc-2020-001230

Figure 3.

Figure 3

Non-canonical programmed cell death 1 (PD-1) signaling in tumorous B cells. Hepatocellular carcinoma (HCC) factors induce PD-1high B cells through TLR4-driven Bcl-6 upregulation. By engagement with PD-L1, non-canonical PD-1 signaling in B cells inhibits antitumor immunity by enhancing IL-10 production. PD-1 blockade decreases interleukin (IL)-10 production and promotes proliferation and differentiation into a memory phenotype of B cells, which may influence efficacy of PD-1 blockade therapy.